102 related articles for article (PubMed ID: 25929598)
21. Recurrence of nephrotic syndrome following kidney transplantation in a child with congenital nephrotic syndrome.
Derakhshan A; Derakhshan D; Fallahzadeh MH; Basiratnia M
Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):150-2. PubMed ID: 26787584
[TBL] [Abstract][Full Text] [Related]
22. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment with rituximab of immunotactoid glomerulopathy exhibiting nephrotic syndrome
.
Karasawa K; Uchida K; Nakano T; Moriyama T; Nitta K
Clin Nephrol; 2018 Sep; 90(3):222-226. PubMed ID: 30049299
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of nephrotic syndrome caused by recurrent IgA nephropathy with chronic active antibody-mediated rejection three years after kidney transplantation.
Yaginuma T; Yamamoto H; Mitome J; Kobayashi A; Yamamoto I; Tanno Y; Hayakawa H; Miyazaki Y; Yokoyama K; Utsunomiya Y; Miki J; Yamada H; Furuta N; Yamaguchi Y; Hosoya T
Clin Transplant; 2011 Jul; 25 Suppl 23():28-33. PubMed ID: 21623911
[TBL] [Abstract][Full Text] [Related]
25. Rituximab for post-transplant recurrences of FSGS.
Bayrakci US; Baskin E; Sakalli H; Karakayali H; Haberal M
Pediatr Transplant; 2009 Mar; 13(2):240-3. PubMed ID: 18822107
[TBL] [Abstract][Full Text] [Related]
26. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T
Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
[TBL] [Abstract][Full Text] [Related]
27. Recurrence of anti-neutrophil cytoplasmic antibody vasculitis in the kidney allograft.
Lau D; Summers S; Amos L; Simpson I; Mulley W
Nephrology (Carlton); 2012 Apr; 17 Suppl 1():16-9. PubMed ID: 22497649
[TBL] [Abstract][Full Text] [Related]
28. Early recurrence of active IgA nephropathy after kidney transplantation.
Otsuka Y; Takeda A; Horike K; Inaguma D; Goto N; Watarai Y; Morozumi K
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():45-8. PubMed ID: 24842823
[TBL] [Abstract][Full Text] [Related]
29. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience.
Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P
Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802
[TBL] [Abstract][Full Text] [Related]
30. Intravenous immunoglobulins and rituximab therapy for severe transplant glomerulopathy in chronic antibody-mediated rejection: a pilot study.
Bachelet T; Nodimar C; Taupin JL; Lepreux S; Moreau K; Morel D; Guidicelli G; Couzi L; Merville P
Clin Transplant; 2015 May; 29(5):439-46. PubMed ID: 25739833
[TBL] [Abstract][Full Text] [Related]
31. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
Wéclawiak H; Ribes D; Modesto A; Kamar N; Durand D; Rostaing L
Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303
[TBL] [Abstract][Full Text] [Related]
32. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
Kisner T; Burst V; Teschner S; Benzing T; Kurschat CE
Nephron Clin Pract; 2012; 120(2):c79-85. PubMed ID: 22286071
[TBL] [Abstract][Full Text] [Related]
33. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
Peters HP; van de Kar NC; Wetzels JF
Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
[TBL] [Abstract][Full Text] [Related]
34. Membranous nephropathy with chronic renal failure. Partial native renal function recovery after unsuccessful renal transplant.
Chopra S; Kaufman JS; Hamburger RJ; Flamenbaum W
Arch Intern Med; 1980 Mar; 140(3):437-8. PubMed ID: 6987969
[No Abstract] [Full Text] [Related]
35. De novo minimal change disease after ABO-incompatible kidney transplantation.
Mochizuki Y; Iwata T; Nishikido M; Uramatsu T; Sakai H; Taguchi T
Clin Transplant; 2012 Jul; 26 Suppl 24():81-5. PubMed ID: 22747482
[TBL] [Abstract][Full Text] [Related]
36. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
Dello Strologo L; Guzzo I; Laurenzi C; Vivarelli M; Parodi A; Barbano G; Camilla R; Scozzola F; Amore A; Ginevri F; Murer L
Transplantation; 2009 Aug; 88(3):417-20. PubMed ID: 19667947
[TBL] [Abstract][Full Text] [Related]
37. Dysplasia of tubular cells in a kidney- transplanted patient treated with recombinant human growth hormone.
Herman J; Van Damme B; Van Damme-Lombaerts R
Pediatr Transplant; 2001 Dec; 5(6):463-6. PubMed ID: 11737773
[TBL] [Abstract][Full Text] [Related]
38. Single low-dose rituximab for the treatment of steroid-resistant nephrotic syndrome with acute kidney injury.
Ashikaga E; Uda S; Kamata K; Shikida Y; Inoue T; Kuno Y; Yao A; Nakamura M; Kai K
CEN Case Rep; 2016 May; 5(1):56-60. PubMed ID: 28509183
[TBL] [Abstract][Full Text] [Related]
39. Treatment of steroid resistant nephrotic syndrome in children.
Kari JA; Halawani M
Saudi J Kidney Dis Transpl; 2010 May; 21(3):484-7. PubMed ID: 20427873
[TBL] [Abstract][Full Text] [Related]
40. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
